Ken Griffin Organogenesis Holdings Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$2.28 - $3.03 $1,367 - $1,817	-600 Reduced 60.0%	400 $1,000
Q1 2024 May 15, 2024	SELL	$2.61 - $4.49 $7,047 - $12,123	-2,700 Reduced 72.97%	1,000 $2,000
Q4 2023 Feb 14, 2024	SELL	$1.97 - $4.21 $16,745 - $35,785	-8,500 Reduced 69.67%	3,700 $15,000
Q3 2023 Nov 14, 2023	SELL	$2.34 - $4.43 $2,106 - $3,986	-900 Reduced 6.87%	12,200 $38,000
Q2 2023 Aug 14, 2023	SELL	$1.9 - $4.3 $34,200 - $77,400	-18,000 Reduced 57.88%	13,100 $43,000
Q1 2023 May 15, 2023	BUY	$1.89 - $2.93 $41,958 - $65,046	22,200 Added 249.44%	31,100 $66,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.43 $22,072 - $30,527	8,900 New	8,900 $23,000

120

62.3M

28.8K

27.9K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $346M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.